Onyx ONE Acute Coronary Syndromes (ACS) Subanalysis - TCT Connect 2020
Onyx ONE: aspirin vs. P2Y12 after 1-month dual antiplatelet therapy for high bleeding risk patients
Onyx ONE Clear Complex PCI Subanalysis - TCT Connect 2020
CRT 2020: Onyx One Global Study: MI predictors — Dr Azeem Latib
Is 1-Month Dual Antiplatelet Therapy Safe? Reconciling MASTER DAPT and STOPDAPT-2
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli
TCT2020 summary and overview of day 1 #TCTConnect
STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS | Dr Hirotoshi Watanabe
TCT 2025: INFINITY-SWEDEHEART: Long-Term Bioadaptor Outcomes
Recent Update on DAPT Strategy for PCI Patients, Prof. Lee, Won Jae
Short Duration DAPT and DAPT De-Escalation: The New Era of DAPT Post-PCI
MASTER DAPT clinical trial review
Drugs and devices synergy: optimal DAPT & switching strategies - Round Table Webinar
One month DAPT is the new standard of care for stable patients?_Baber_Coronary On Demand
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI | Dr Davide Cao
#TCT2020 DAY 1 WRAP UP with Chadi Alraies, MD
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting - AICT-AsiaPCR 2021
ISAR-REACT 4, TRITON-TIMI 38, ICD Risk
MASTER DAPT
SYNERGY - High-bleeding risk patients and DAPT
